Hugh Desaix Riordan, M.D.
Hall of Fame 2005
"Hugh Riordan was an amazing influence on my family and on all who knew him."
Of all the medical mavericks, Hugh Riordan was one of the most knowledgeable, both as a maverick par excellence and as an historian of mavericks. Hugh was an orthomolecular fighter, who fought hard and consistently on behalf of orthomolecular concepts. He was challenged legally when he wanted to treat his patients with high dose vitamins in the hospital. He won. He was the first to demonstrate how large doses of vitamin C are chemotherapeutic for cancer patients. He was a pioneer in establishing the new vitamins-as-treatment paradigm.
"We worked together on the editorial board of the Journal of Orthomolecular Medicine, and on the board of the International Schizophrenia Foundation. Hugh joined the editorial board of JOM in 1991, then became Associate Editor in 2000. He published several books, including three volumes of Medical Mavericks, and about 70 clinical and research reports. His main work had to do with the schizophrenic syndrome and with the treatment of cancer using nontoxic vitamin C chemotherapy. Hugh was the leader in making available to cancer patients a treatment that is effective, safe, economical and very tolerable. Few oncologists have ever seen these advantages unless they visited Hugh's clinic. The vitamin C intravenous chemotherapy studies established so well by Dr. Riordan are being continued at the University of Kansas and McGill University, Montreal. In 2002, Hugh was honored by International Society for Orthomolecular Medicine with the "Orthomolecular Physician of the Year" award. He worked tirelessly, founding and developing the Center for the Improvement of Human Functioning International Inc. as a superb treatment center." This year, the Center celebrates its 30th anniversary. Hugh's dedicated staff of more than 70 like-minded medical mavericks continue their founder's pioneering work. (www.RiordanClinic.org)
Submitted by Abram Hoffer, M.D., Ph.D.